HomeNews

News

Focusing Analysis on T-Cell ALL to Additional Remedy Choices

Important developments in treating B-cell acute lymphoblastic leukemia (ALL) with progressive therapies like CAR-T cell remedy have surfaced lately. Nonetheless, sufferers with T-cell...

Opdivo Combo Exhibits Higher Survival Advantages in Superior Hodgkin Lymphoma

Opdivo plus chemotherapy considerably improved survival and lowered negative effects in comparison with Adcetris plus chemotherapy in sufferers with superior Hodgkin lymphoma.Adolescents and...

Opdivo Could Enhance Outcomes in Excessive-Threat Muscle-Invasive Bladder Most cancers

Adjuvant Opdivo improved total and disease-free survival for sufferers with high-risk muscle-invasive urothelial most cancers after radical resection.Lately printed findings assist adjuvant Opdivo...

FDA Accepts New Drug Utility for Nubeqa Combo for Prostate Most cancers Subset

A brand new drug utility for Nubeqa, a possible remedy for sufferers with metastatic hormone-sensitive prostate most cancers, was accepted by the FDA.The...

A Survivor’s Thanksgiving: Celebrating Life’s Blessings Put up-Most cancers

Tamron Little was recognized with peritoneal mesothelioma in 2007 as a 21-year-old new mom. Atone for Tamron's blogs right here!Thanksgiving is a season...

Hot Topics